Subject: RG1-991 | Research Article | Gynecology and obstetrics | Article Subject
Background. There is little knowledge regarding the characteristics of women treated with hypnotic benzodiazepine receptor agonists (HBRAs) during pregnancy. In this large Danish cohort study, we characterize women exposed to HBRA during pregnancy. We determined changes... View more
Tamanna, S., Geraci, S. A.. Major sleep disorders among women: (Women’s Health Series).
Southern Medical Journal. 2013; 106 (8): 470-478
Hutchison, B. L., Stone, P. R., McCowan, L. M. E., Stewart, A. W., Thompson, J. M. D., Mitchell, E.. A postal survey of maternal sleep in late pregnancy.
BMC Pregnancy Childbirth. 2012; 12 (1): 144
Roehrs, T., Roth, T.. Hypnotics: an update.
Current Neurology and Neuroscience Reports. 2003; 3 (2): 181-184
Lader, M.. Zopiclone: is there any dependence and abuse potential?.
Journal of Neurology, Supplement. 1997; 244 (1): S18-S22
Dang, A., Garg, A., Rataboli, P. V.. Role of Zolpidem in the Management of Insomnia.
CNS Neuroscience and Therapeutics. 2011; 17 (5): 387-397
Giorgi, M., Portela, D. A., Breghi, G., Briganti, A.. Pharmacokinetics and pharmacodynamics of zolpidem after oral administration of a single dose in dogs.
American Journal of Veterinary Research. 2012; 73 (10): 1650-1656
Juric, S., Newport, D. J., Ritchie, J. C., Galanti, M., Stowe, Z. N.. Zolpidem (Ambien) in pregnancy: placental passage and outcome.
Archives of Women's Mental Health. 2009; 12 (6): 441-446
Wang, L.-H., Lin, H.-C., Lin, C.-C., Chen, Y.-H., Lin, H.-C.. Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy.
Clinical Pharmacology and Therapeutics. 2010; 88 (3): 369-374
Wikner, B. N., Stiller, C.-O., Bergman, U., Asker, C., Källén, B.. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.
Pharmacoepidemiology and Drug Safety. 2007; 16 (11): 1203-1210
Wikner, B. N., Källén, B.. Are hypnotic benzodiazepine receptor agonists teratogenic in humans?.
Journal of Clinical Psychopharmacology. 2011; 31 (3): 356-359